改善造血干细胞移植的治疗效果：近期进展
Improving Outcomes in Hematopoietic Stem Cell Transplant: Recent Advances.
作者信息
Alencar Maritza
机构信息
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida.
出版信息
J Adv Pract Oncol. 2021 Apr;12(3):333-336. doi: 10.6004/jadpro.2021.12.3.25. Epub 2021 Apr 1.
Abstract
During JADPRO Live Virtual 2020, Maritza Alencar, DNP, MBA, APRN-BC, BMTCN, described advances in the management and prevention of infectious disease complications and graft-vs.-host disease following transplant. Dr. Alencar also emphasized the role of advanced practitioners in post-transplant care.
摘要
在2020年JADPRO现场虚拟会议期间，拥有护理学博士学位、工商管理硕士学位、美国护理认证中心认证的高级实践注册护士、血液管理认证护士的玛丽莎·阿伦卡尔介绍了移植后传染病并发症和移植物抗宿主病管理与预防方面的进展。阿伦卡尔博士还强调了高级从业者在移植后护理中的作用。
相似文献
1
Improving Outcomes in Hematopoietic Stem Cell Transplant: Recent Advances.改善造血干细胞移植的治疗效果：近期进展
J Adv Pract Oncol. 2021 Apr;12(3):333-336. doi: 10.6004/jadpro.2021.12.3.25. Epub 2021 Apr 1.
2
Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer.心脏肿瘤学：心血管疾病与癌症的交叉领域
J Adv Pract Oncol. 2021 Apr;12(3):253-256. doi: 10.6004/jadpro.2021.12.3.6. Epub 2021 Apr 1.
3
Developments in Hepatocellular Cancer Treatment.肝细胞癌治疗的进展
J Adv Pract Oncol. 2021 Apr;12(3):310-314. doi: 10.6004/jadpro.2021.12.3.19. Epub 2021 Apr 1.
4
Severe sepsis in hematopoietic stem cell transplant recipients*.造血干细胞移植受者中的严重脓毒症*。
Crit Care Med. 2015 Feb;43(2):411-21. doi: 10.1097/CCM.0000000000000714.
5
Diagnosis and Treatment of AL and ATTR Amyloidosis.AL型和ATTR型淀粉样变性的诊断与治疗
J Adv Pract Oncol. 2021 Apr;12(3):329-332. doi: 10.6004/jadpro.2021.12.3.24. Epub 2021 Apr 1.
6
Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know.直接口服抗凝剂与癌症血栓形成：抗凝药师需要了解的内容
J Adv Pract Oncol. 2022 Apr;13(3):253-256. doi: 10.6004/jadpro.2022.13.3.14. Epub 2022 May 23.
7
Cardio-Oncology Considerations in Oncologic Treatment Decisions.肿瘤治疗决策中的心脏肿瘤学考量
J Adv Pract Oncol. 2022 Apr;13(3):237-242. doi: 10.6004/jadpro.2022.13.3.11. Epub 2022 May 23.
8
Advances in critical care of the pediatric hematopoietic stem cell transplant patient.儿科造血干细胞移植患者重症监护的进展。
Pediatr Clin North Am. 2013 Jun;60(3):689-707. doi: 10.1016/j.pcl.2013.02.007. Epub 2013 Mar 12.
9
Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis.造血干细胞移植与 HLA 不匹配供体：供体、来源、预处理和移植物抗宿主病预防的影响。
Expert Rev Hematol. 2019 Jan;12(1):47-60. doi: 10.1080/17474086.2019.1562331. Epub 2018 Dec 29.
10
A review of late complications of allogeneic hematopoietic stem cell transplantations.异基因造血干细胞移植晚期并发症综述。
Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13062. Epub 2017 Aug 21.
本文引用的文献
1
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.芦可替尼治疗糖皮质激素难治性急性移植物抗宿主病。
N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22.
2
Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients.巨细胞病毒病毒载量对异基因造血干细胞移植受者自发清除率和抢先治疗反应的影响。
Biol Blood Marrow Transplant. 2018 Apr;24(4):806-814. doi: 10.1016/j.bbmt.2017.11.038. Epub 2017 Dec 5.
3
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.伊布替尼用于既往治疗失败后的慢性移植物抗宿主病。
Blood. 2017 Nov 23;130(21):2243-2250. doi: 10.1182/blood-2017-07-793786. Epub 2017 Sep 18.
4
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.来那度胺维持治疗在新诊断的多发性骨髓瘤自体干细胞移植后的应用：一项荟萃分析。
J Clin Oncol. 2017 Oct 10;35(29):3279-3289. doi: 10.1200/JCO.2017.72.6679. Epub 2017 Jul 25.
5
Recent advances in hematopoietic stem cell transplantation.造血干细胞移植的最新进展
F1000Res. 2017 Jun 12;6:870. doi: 10.12688/f1000research.11233.1. eCollection 2017.
6
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.本妥昔单抗维泊妥珠单抗作为自体造血干细胞移植后巩固治疗在有复发或进展风险的霍奇金淋巴瘤患者中的应用（AETHERA）：一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2015 May 9;385(9980):1853-62. doi: 10.1016/S0140-6736(15)60165-9. Epub 2015 Mar 19.
7
Prevalence of hematopoietic cell transplant survivors in the United States.美国造血细胞移植幸存者的患病率。
Biol Blood Marrow Transplant. 2013 Oct;19(10):1498-501. doi: 10.1016/j.bbmt.2013.07.020. Epub 2013 Jul 30.
8
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.泊沙康唑与氟康唑或伊曲康唑对中性粒细胞减少患者的预防作用比较
N Engl J Med. 2007 Jan 25;356(4):348-59. doi: 10.1056/NEJMoa061094.
Zotero 插件